NEW YORK (MarketWatch)
Johnson & Johnson said
Tuesday its second-quarter profit dropped 49% to $1.41 billion, or 50 cents a
share, from $2.78 billion, or $1 a share, in the year-ago period
Adjusted
profit in the latest quarter totaled $1.30 a share, after breaking out one-time
items
Sales fell 0.7% to $16.48 billion
Wall Street analysts expected the
pharmaceutical and health products company to earn $1.29 a share on sales of
$16.68 billion, according to a survey by FactSet Research
Looking ahead,
J&J expects adjusted 2012 earnings of $5 to $5.07 a share, compared to the
analyst forecast of $5.14 a share
Welcome
The mathematician of the Complutense University of Madrid, José-Vidal Ruiz Varela, argues that Europe must raise its borrowing limit, leaving its deflationary policy.
Cortesía de Investing.com
Agenda Macro
Calendario económico en tiempo real proporcionado por Investing.com España.
No hay comentarios:
Publicar un comentario